Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/23808
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | BARREIRA, Eliane Roseli | - |
dc.contributor.author | PRECIOSO, Alexander Roberto | - |
dc.contributor.author | BOUSSO, Albert | - |
dc.date.accessioned | 2017-11-27T16:39:40Z | - |
dc.date.available | 2017-11-27T16:39:40Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | PEDIATRIC PULMONOLOGY, v.46, n.5, p.415-420, 2011 | - |
dc.identifier.issn | 8755-6863 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/23808 | - |
dc.description.abstract | Respiratory syncytial virus (RSV) bronchiolitis is the leading cause of lower respiratory tract infection, and the most frequent reason for hospitalization among infants throughout the world. In addition to the acute consequences of the disease, RSV bronchiolitis in early childhood is related to further development of recurrent wheezing and asthma. Despite the medical and economic burden of the disease, therapeutic options are limited to supportive measures, and mechanical ventilation in severe cases. Growing evidence suggests an important role of changes in pulmonary surfactant content and composition in the pathogenesis of severe RSV bronchiolitis. Besides the well-known importance of pulmonary surfactant in maintenance of pulmonary homeostasis and lung mechanics, the surfactant proteins SP-A and SP-D are essential components of the pulmonary innate immune system. Deficiencies of such proteins, which develop in severe RSV bronchiolitis, may be related to impairment in viral clearance, and exacerbated inflammatory response. A comprehensive understanding of the role of the pulmonary surfactant in the pathogenesis of the disease may help the development of new treatment strategies. We conducted a review of the literature to analyze the evidences of pulmonary surfactant changes in the pathogenesis of severe RSV bronchiolitis, its relation to the inflammatory and immune response, and the possible role of pulmonary surfactant replacement in the treatment of the disease. Pediatr Pulmonol. 2011; 46:415-420. (c) 2010 Wiley-Liss, Inc. | - |
dc.language.iso | eng | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.relation.ispartof | Pediatric Pulmonology | - |
dc.rights | restrictedAccess | - |
dc.subject | bronchiolitis | - |
dc.subject | respiratory syncytial virus | - |
dc.subject | human | - |
dc.subject | pulmonary surfactants | - |
dc.subject.other | a-deficient mice | - |
dc.subject.other | protein-a | - |
dc.subject.other | high-risk | - |
dc.subject.other | in-vivo | - |
dc.subject.other | lung collectins | - |
dc.subject.other | innate immunity | - |
dc.subject.other | infection | - |
dc.subject.other | infants | - |
dc.subject.other | children | - |
dc.subject.other | disease | - |
dc.title | Pulmonary Surfactant in Respiratory Syncytial Virus Bronchiolitis: The Role in Pathogenesis and Clinical Implications | - |
dc.type | article | - |
dc.rights.holder | Copyright WILEY-BLACKWELL | - |
dc.identifier.doi | 10.1002/ppul.21395 | - |
dc.identifier.pmid | 21194166 | - |
dc.subject.wos | Pediatrics | - |
dc.subject.wos | Respiratory System | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.beginpage | 415 | - |
hcfmusp.description.endpage | 420 | - |
hcfmusp.description.issue | 5 | - |
hcfmusp.description.volume | 46 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-79954483603 | - |
hcfmusp.origem.id | WOS:000289510500001 | - |
hcfmusp.publisher.city | HOBOKEN | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Krishnan S, 2004, VIRAL IMMUNOL, V17, P220, DOI 10.1089/0882824041310612 | - |
hcfmusp.relation.reference | Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840 | - |
hcfmusp.relation.reference | Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004 | - |
hcfmusp.relation.reference | Ghildyal R, 1999, J INFECT DIS, V180, P2009, DOI 10.1086/315134 | - |
hcfmusp.relation.reference | Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014 | - |
hcfmusp.relation.reference | Dargaville PA, 1996, ARCH DIS CHILD, V75, P133 | - |
hcfmusp.relation.reference | LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0 | - |
hcfmusp.relation.reference | Bernhard W, 2000, AM J RESP CRIT CARE, V162, P1524 | - |
hcfmusp.relation.reference | El Saleeby CM, 2010, J PEDIATR-US, V156, P409, DOI 10.1016/j.jpeds.2009.09.043 | - |
hcfmusp.relation.reference | LeVine AM, 2001, J IMMUNOL, V167, P5868 | - |
hcfmusp.relation.reference | LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC | - |
hcfmusp.relation.reference | Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014 | - |
hcfmusp.relation.reference | van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x | - |
hcfmusp.relation.reference | Barr FE, 2000, AM J RESP CELL MOL, V23, P586 | - |
hcfmusp.relation.reference | Luchetti M, 1998, ACTA ANAESTH SCAND, V42, P805 | - |
hcfmusp.relation.reference | Hickling TP, 1999, EUR J IMMUNOL, V29, P3478, DOI 10.1002/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.3.CO;2-N | - |
hcfmusp.relation.reference | Kerr MH, 1999, AM J RESP CRIT CARE, V159, P1115 | - |
hcfmusp.relation.reference | Linke MJ, 2001, J INFECT DIS, V183, P943, DOI 10.1086/319252 | - |
hcfmusp.relation.reference | LeVine AM, 1996, CRIT CARE MED, V24, P1062, DOI 10.1097/00003246-199606000-00029 | - |
hcfmusp.relation.reference | Wang EEL, 1996, J PEDIATR-US, V129, P390, DOI 10.1016/S0022-3476(96)70071-9 | - |
hcfmusp.relation.reference | Null D, 1998, PEDIATRICS, V102, P531 | - |
hcfmusp.relation.reference | Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528 | - |
hcfmusp.relation.reference | Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X | - |
hcfmusp.relation.reference | Yorita KL, 2008, PEDIATRICS, V121, P244, DOI 10.1542/peds.2007-1392 | - |
hcfmusp.relation.reference | Welliver RC, 2010, CURR MED RES OPIN, V26, P2175, DOI 10.1185/03007995.2010.505126 | - |
hcfmusp.relation.reference | Harris J, 2003, CELL MICROBIOL, V5, P671, DOI 10.1046/j.1462-5822.2003.00313.x | - |
hcfmusp.relation.reference | Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087 | - |
hcfmusp.relation.reference | LeVine AM, 2000, J IMMUNOL, V165, P3934 | - |
hcfmusp.relation.reference | LeVine AM, 1999, J CLIN INVEST, V103, P1015, DOI 10.1172/JCI5849 | - |
hcfmusp.relation.reference | Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092 | - |
hcfmusp.relation.reference | Bonnet D, 2005, CARDIOL YOUNG, V15, P256, DOI 10.1017/S1047951105000545 | - |
hcfmusp.relation.reference | Carbonell-Estrany X, 2010, PEDIATRICS, V125, pE35, DOI 10.1542/peds.2008-1036 | - |
hcfmusp.relation.reference | Chiba H, 2006, RESPIROLOGY, V11, pS2, DOI 10.1111/j.1440-1843.2006.00797.x | - |
hcfmusp.relation.reference | Davison Caroline, 2004, Pediatr Crit Care Med, V5, P482, DOI 10.1097/01.PCC.0000128891.54799.67 | - |
hcfmusp.relation.reference | GLEZEN WP, 1973, NEW ENGL J MED, V288, P498, DOI 10.1056/NEJM197303082881005 | - |
hcfmusp.relation.reference | Enhorning G, 2008, CHEST, V133, P975, DOI 10.1378/chest.07-2404 | - |
hcfmusp.relation.reference | Griese M, 2008, PEDIATR ALLERGY IMMU, V19, P639, DOI 10.1111/j.1399-3038.2007.00695.x | - |
hcfmusp.relation.reference | Hamm H, 1996, RESP MED, V90, P251, DOI 10.1016/S0954-6111(96)90097-9 | - |
hcfmusp.relation.reference | Lahti M, 2002, PEDIATR RES, V51, P696, DOI 10.1023/01.PDR.0000015911.65104.93 | - |
hcfmusp.relation.reference | Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9 | - |
hcfmusp.relation.reference | LeVine AM, 1998, AM J RESP CELL MOL, V19, P700 | - |
hcfmusp.relation.reference | Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06 | - |
hcfmusp.relation.reference | Luchetti M., 2002, Pediatric Critical Care Medicine, V3, P261, DOI 10.1097/00130478-200207000-00011 | - |
hcfmusp.relation.reference | NAKAMURA M, 2009, P AM THORAC SOC, V6, P322 | - |
hcfmusp.relation.reference | Ochoa Sangrador C, 2010, AN PEDIAT BARC, V72 | - |
hcfmusp.relation.reference | Puthothu Beena, 2007, BMC Pulm Med, V7, P6, DOI 10.1186/1471-2466-7-6 | - |
hcfmusp.relation.reference | Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55 | - |
hcfmusp.relation.reference | SIGURS N, 2010, THORAX 0627 | - |
hcfmusp.relation.reference | Skelton R, 1999, ACTA PAEDIATR, V88, P942, DOI 10.1080/08035259950168414 | - |
hcfmusp.relation.reference | Tibby SM, 2000, AM J RESP CRIT CARE, V162, P1251 | - |
hcfmusp.relation.reference | VanSchaik SM, 1997, PEDIATR RES, V42, P169, DOI 10.1203/00006450-199708000-00007 | - |
hcfmusp.relation.reference | VENKITARAMAN AR, 1991, CHEM PHYS LIPIDS, V57, P49, DOI 10.1016/0009-3084(91)90048-G | - |
hcfmusp.relation.reference | VENTRE K, 2007, COCHRANE DATABASE SY, V24 | - |
hcfmusp.relation.reference | Ventre K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005150.pub2 | - |
hcfmusp.relation.reference | Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387 | - |
hcfmusp.relation.reference | World Health Organization, AC RESP INF | - |
dc.description.index | MEDLINE | - |
dc.identifier.eissn | 1099-0496 | - |
hcfmusp.citation.scopus | 20 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICr Artigos e Materiais de Revistas Científicas - HU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_BARREIRA_Pulmonary_Surfactant_in_Respiratory_Syncytial_Virus_Bronchiolitis_The_2011.PDF Restricted Access | publishedVersion (English) | 66.27 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.